Last Updated : December 10, 2024
Industry input is used by us to gain feedback on the project scope of a non-sponsored reimbursement review. The industry input summary and individual submissions are included in the committee briefing materials. Input from industry is submitted to us by manufacturers or sponsors of drugs that are under review.
Industry has a total of 35 business days to prepare and submit their input from the date of the open calls for input. We send out notifications for these open calls every Thursday, through our Weekly Summary. Calls for industry input are also highlighted on the open calls page of our website.
To participate:
Following our review and the expert committee deliberations, draft reimbursement recommendations are shared for feedback. New draft recommendations and open calls for feedback are highlighted in our Weekly Summary.
To participate:
If you have questions or need help to participate, please contact [email protected].
To learn more about our non-sponsored reimbursement review process, you can go to the Procedures for our Non-Sponsored Reimbursement Reviews.